Centerpoint Advisory Group cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 20.9% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 716 shares of the healthcare conglomerate’s stock after selling 189 shares during the quarter. Centerpoint Advisory Group’s holdings in UnitedHealth Group were worth $375,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also bought and sold shares of UNH. Fort Washington Investment Advisors Inc. OH lifted its position in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after purchasing an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $515,000. Full Sail Capital LLC boosted its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares during the last quarter. Soros Fund Management LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its position in UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after purchasing an additional 12,550 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $302.04 on Monday. The firm has a market cap of $273.99 billion, a price-to-earnings ratio of 12.65, a P/E/G ratio of 1.42 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a fifty day moving average price of $359.15 and a 200 day moving average price of $461.96.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 37.02%.
Insider Activity at UnitedHealth Group
In other news, Director Kristen Gil purchased 3,700 shares of the firm’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. 0.28% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
UNH has been the topic of several recent research reports. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective on the stock. in a research report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $427.09.
Check Out Our Latest Research Report on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- How Can Investors Benefit From After-Hours Trading
- The Boring Is Beautiful Portfolio: 3 Stocks for a Worried World
- What Are the FAANG Stocks and Are They Good Investments?
- More Than a Monetary Metal: Silver’s Case for Outperformance
- 3 Small Caps With Big Return Potential
- Retail Sales Signal Upside for These 3 Consumer Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.